Read the full article below.
News
21/03/2025
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS)
Our news
News
05/06/2025
The European Microbiome Innovation for Health Association Welcomes 13 New Members, Strengthening Europe’s Leadership in Microbiome Innovation
> READ
The European Microbiome Innovation for Health Association Welcomes 13 New Members, Strengthening Europe’s Leadership in Microbiome Innovation
> READ
News
05/05/2026
MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis
> READ
MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis
> READ
News
23/09/2024
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
> READ
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
> READ
> See all news